Nanomolar affinity, iminosugar-based chemical probes for specific labeling of lysosomal glucocerebrosidase

被引:25
作者
van Scherpenzeel, Monique [1 ]
van den Berg, Richard J. B. H. N. [2 ]
Donker-Koopman, Wilma E. [3 ]
Liskamp, Rob M. J. [1 ]
Aerts, Johannes M. F. G. [3 ]
Overkleeft, Herman S. [2 ]
Pieters, Roland J. [1 ]
机构
[1] Univ Utrecht, Dept Med Chem & Chem Biol, Utrecht Inst Pharmaceut Sci, NL-3508 TB Utrecht, Netherlands
[2] Leiden Univ, Gorlaeus Labs, Dept Bioorgan Synth, Leiden Inst Chem, NL-2300 RA Leiden, Netherlands
[3] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, NL-1105 AZ Amsterdam, Netherlands
关键词
Glucosidases; Proteomics probes; Photolabeling; BETA-GLUCOSIDASE; GAUCHER-DISEASE; PROTEIN IDENTIFICATION; MASS-SPECTROMETRY; GALECTIN-3; INHIBITORS; GLYCOSIDASES; MECHANISM; DEOXYNOJIRIMYCIN; PROTEOMICS;
D O I
10.1016/j.bmc.2009.10.060
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Three different photoprobes were synthesized to label beta-glucosidases; one probe was based on glucose, two probes on the iminosugar deoxynojirimycin. The affinity of the probes for three different beta-glucosidases was determined. Furthermore, their labeling efficiencies, binding specificities through competition with deoxynojirimycin, and binding specificities in the presence of cell lysate, were evaluated. Especially one showed very high affinity towards non-lysosomal glucoceramidase (IC50 = 20 nM). (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:267 / 273
页数:7
相关论文
共 34 条
[1]   PATHOGENESIS OF LYSOSOMAL STORAGE DISORDERS AS ILLUSTRATED BY GAUCHER DISEASE [J].
AERTS, JMFG ;
VANWEELY, S ;
BOOT, R ;
HOLLAK, CEM ;
TAGER, JM .
JOURNAL OF INHERITED METABOLIC DISEASE, 1993, 16 (02) :288-291
[2]   A new chemical probe for proteomics of carbohydrate-binding proteins [J].
Ballell, L ;
Alink, KJ ;
Slijper, M ;
Versluis, C ;
Liskamp, RMJ ;
Pieters, RJ .
CHEMBIOCHEM, 2005, 6 (02) :291-295
[3]   A new chemical probe for the detection of the cancer-linked galectin-3 [J].
Ballell, Lluis ;
van Scherpenzeel, Monique ;
Buchalova, Katerina ;
Liskamp, Rob M. J. ;
Pieters, Roland J. .
ORGANIC & BIOMOLECULAR CHEMISTRY, 2006, 4 (23) :4387-4394
[4]   GAUCHER DISEASE - NEW MOLECULAR APPROACHES TO DIAGNOSIS AND TREATMENT [J].
BEUTLER, E .
SCIENCE, 1992, 256 (5058) :794-799
[5]   Gaucher cells demonstrate a distinct macrophage phenotype and resemble alternatively activated macrophages [J].
Boven, LA ;
van Meurs, M ;
Boot, RG ;
Mehta, A ;
Boon, L ;
Aerts, JM ;
Laman, JD .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2004, 122 (03) :359-369
[6]   Crystal structures of complexes of N-butyl- and N-nonyl-deoxynojirimycin bound to acid β-glucosidase -: Insights into the mechanism of chemical chaperone action in Gaucher disease [J].
Brumshtein, Boris ;
Greenblatt, Harry M. ;
Butters, Terry D. ;
Shaaltiel, Yoseph ;
Aviezer, David ;
Silman, Israel ;
Futerman, Anthony H. ;
Sussman, Joel L. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (39) :29052-29058
[7]  
Corthals GL, 2000, ELECTROPHORESIS, V21, P1104, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1104::AID-ELPS1104>3.3.CO
[8]  
2-3
[9]   C2-symmetrical thiodigalactoside bis-benzamido derivatives as high-affinity inhibitors of galectin-3:: efficient lectin inhibition through double arginine-arene interactions [J].
Cumpstey, I ;
Sundin, A ;
Leffler, H ;
Nilsson, UJ .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2005, 44 (32) :5110-5112
[10]   REVERSIBLE INHIBITORS OF BETA-GLUCOSIDASE [J].
DALE, MP ;
ENSLEY, HE ;
KERN, K ;
SASTRY, KAR ;
BYERS, LD .
BIOCHEMISTRY, 1985, 24 (14) :3530-3539